Keyphrases
Adults with Down Syndrome
9%
Aging
13%
AIDS/HIV
20%
Alzheimer's Disease
78%
Alzheimer's Disease Biomarkers
9%
Alzheimer's Disease Pathology
14%
Amyloid Positron Emission Tomography
7%
Antiretroviral Therapy
6%
Autosomal Dominant Alzheimer's Disease
15%
Blood Flow
6%
Brain Aging
6%
Central Nervous System
9%
Cerebral Blood Flow
17%
Cerebrospinal Fluid
19%
Cognitive Function
7%
Cognitive Impairment
16%
Cognitive Performance
6%
Cognitively Normal
16%
Cognitively Normal Older Adults
7%
Combined Antiretroviral Therapy (cART)
13%
Dementia
6%
Down Syndrome
21%
Flow Coupling
6%
Forepaw Stimulation
7%
Functional Connectivity
15%
Functional Magnetic Resonance Imaging
6%
HIV Infection
7%
HIV Patients
10%
HIV+
11%
HIV-associated Neurocognitive Disorders
17%
Imaging Biomarkers
6%
Magnetic Resonance Imaging
8%
Mild Cognitive Impairment
8%
Neurodegeneration
11%
Neurofilament Light (NF-L)
7%
Neuroimaging
18%
Neurologic Complications
9%
Older Adults
10%
Opportunistic Infections
8%
People Living with HIV (PLHIV)
29%
Positron Emission Tomography
14%
Resting-state Functional Connectivity (rs-FC)
17%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
8%
Retroviral Infection
7%
Sporadic Alzheimer's Disease
21%
Tau Pathology
8%
Tau PET
8%
Tau Positron Emission Tomography
8%
White Matter
6%
White Matter Integrity
7%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
36%
Behavior (Neuroscience)
7%
Blood Plasma
13%
Brain Age
5%
Brain Network
5%
Central Nervous System
5%
Cognitive Disorders
14%
Cognitive Function
5%
Down Syndrome
19%
Fluorine-18
9%
Functional Connectivity
16%
Functional Magnetic Resonance Imaging
13%
HIV Associated Dementia
9%
Human Immunodeficiency Virus
66%
Magnetic Resonance Imaging
10%
Magnetic Resonance Imaging
10%
Metabolic Pathway
8%
Mild Cognitive Impairment
8%
Neurodegeneration
11%
Neurofilament Light Chain
6%
Positron Emission Tomography
19%
Positron Emission Tomography
17%
Resting-State Functional Connectivity
12%
Somatosensory Cortex
8%
Medicine and Dentistry
Alzheimer's Disease
48%
Amyloid Protein
21%
Antiretroviral Therapy
9%
Autosomal Dominant Inheritance
8%
Biological Marker
14%
Brain Blood Flow
6%
Central Nervous System
6%
Cerebrospinal Fluid
10%
Cognitive Defect
5%
Diseases
8%
Down Syndrome
11%
Functional Connectivity
5%
HIV-associated Neurocognitive Disorder
9%
Human Immunodeficiency Virus
35%
Human Immunodeficiency Virus Infection
6%
Magnetic Resonance Imaging
8%
Neurological Complication
7%
Opportunistic Infection
5%
Pittsburgh Compound B
5%
Polyethylene Terephthalate
7%
Positron Emission Tomography
15%
Tau
20%